Article
Do founder mutations characteristic of some cancer sites also predispose to pancreatic cancer?
International journal of cancer - 1 Aug 2016
Lener Marcin R, Scott Rodney J, Kluźniak Wojciech, Baszuk Piotr, Cybulski Cezary, Wiechowska-Kozłowska Anna, Huzarski Tomasz, Byrski Tomasz, Kładny Józef, Pietrzak Sandra, Soluch Agnieszka, Jakubowska Anna, Lubiński Jan
Abstract excerpt
Understanding of the etiology and risk of pancreatic cancer (PaCa) is still poorly understood. This study evaluated the prevalence of 10 Polish founder mutations in four genes among PaCa patients and assessed their possible association with the risk of disease in Poland. In the study 383 PaCa patients and 4,000 control subjects were genotyped for founder mutations in: BRCA1 (5382insC, 4153delA, C61G), CHEK2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
